Genomic medicine and racial/ethnic health disparities: Promises, perils, and the challenges for health care and public health policy

Ethnicity and Disease

Volumn 19, Issue 4, 2009, Pages 473-478

  Moonesinghe, Ramal ^a   Jones, Walter ^b   Honoré, Peggy A ^c   Truman, Benedict I ^a   Graham, Garth ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Allele frequency; Genetic tests; Genomic medicine; Healthcare disparity

Indexed keywords

ETHNICITY; GENE FREQUENCY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; REVIEW; UNITED STATES; ARTICLE; ETHNIC GROUP; GENETIC PREDISPOSITION; HEALTH CARE DISPARITY; MEDICAL GENETICS; PERSONALIZED MEDICINE; PHARMACOGENETICS; PUBLIC HEALTH;

ETHNIC GROUPS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; HEALTHCARE DISPARITIES; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; PUBLIC HEALTH; UNITED STATES;

EID: 77949329769     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Duster T. Lessons from history: why race and ethnicity have played a major role in biomedical research. J Law Med Ethics. 2006;34(3): 487-496. (Pubitemid 44505508)
2. Collins FS, Green ED, Guttmacher AE, et al. A vision for the future of genomic research. Nature. 2003;422:835-847.
3. Fine MJ, Ibrahim SA, Thomas SB. The role of race and genetics in health disparities research. Am J Public Health. 2005;95(12):2125-2127.
4. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington DC: National Academy Press; 2003.
5. US Department of Health and Human Services. OMB Standards for Data on Race and Ethnicity. http://www.omhrc.gov/templates/browse.aspx? lvl52&lvlID5172. Last accessed January 12, 2009.
6. Sankar P, Cho MK, Condit CM, et al. Genetic research and health disparities. JAMA. 2004;291:2985-2989.
7. Lee SS, Mountain J, Koenig B. The meanings of "race" in the new genomics: implications of health disparities research. Yale J Health Policy Law Ethics. 2001;1:33-75.
8. Barnes KC. Genetic epidemiology of health disparities in allergy and clinical immunology. J Allergy Clin Immunol. 2006;117:243-254.
9. David R, Collins J. Disparities in infant mortality: what's genetics got to do with it? Am J Public Health. 2007;97:1191-1197.
10. Palomar L, Defranco EA, Lee KA, Allsworth JE, Muglia LJ. Paternal race is a risk factor for preterm birth. Am J Obstet Gynecol. 2007;197:152.e1-7 (Pubitemid 47198162)
11. Montoya MJ, Howard BM. Dangerous implications of racial genetic research. Am J Obstet Gynecol. 2008;198(4):483.
12. Mendez DD, Spriggs AL. Race as a social construct: the genetic fallacy. Am J Obstet Gynecol. 2008;198(4):484.
13. McGinnis JM, Williams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Aff. 2002;21:78-93.
14. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21:60-76.
15. Ramos RG, Olden K. Gene-environment interactions in the development of complex disease phenotypes. Int J Environ Res Public Health. 2008;5:4-11. (Pubitemid 351480966)
16. Emery J, Hayflick S. The challenge of integrating genetic medicine to primary care. BMJ. 2005;332:1027-1030.
17. Hallman D, Ellsworth D, Boerwinkle E. Molecular and genetic approaches to the study of cardiovascular disease. J Cardiovasc Risk. 1997;4:325-331. (Pubitemid 28078673)
18. Richard F, Helbecque N, Neuman E, Guez D, Levy R, Amouyel P. APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet. 1997;349:359. (Pubitemid 27092795)
19. Matchar DB, Thakur ME, Grossman I, et al. Testing for Cytochrome P450 Polymorphisms in Adults with Non-Psychotic Depression Treated with Selective Serotonin Reuptake Inhibitors (SSRIs). Evidence Report/Technology Assessment No. 146. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-02-0025.) AHRQ Publication No. 07-E002. Rockville,MD: Agency forHealthcare Research and Quality; 2007. http://www.ahrq.gov/downloads/pub/evidence/pdf/ cyp450/cyp450. pdf. Last accessed January 12, 2009.
20. Hudson KL, Holohan MK, Collins FS. Keeping pace with the times - The Genetic Information Nondiscrimination Act of 2008. N Engl J Med. 2008;358(25):2661-2663. (Pubitemid 351860857)
21. AmpliChip CYP450. Specialty Laboratories Website. http://www. specialtylabs.com/education download-PDF/AmpliChip.pdf. Last accessed January 12, 2009.
22. Mountain JL, Cavalli-Sforza LL. Multilocus genotypes, a tree of individuals, and human evolutionary history. Am J Hum Genet. 1997;61:705-718
23. NHANES III Genetic Data. National Center for Health Statistics web site. http://www.cdc.gov/nchs/about/major/nhanes/nh3data-genetic.htm. Accessed June 8, 2008.
24. Chang MH, Lindegren ML, Butler MA, et al. Prevalence in the United States of selected candidate gene variants: third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. Am J Epidemiol. 2009;169: 54-66.
25. Smelser D, Yesupriya A, Ned R, Moonesinghe R. Association of candidate gene polymorphisms with metabolic syndrome and inflammation. Poster presented at: Centers for Disease Control and Prevention Public Health Genomics Meeting; January 23, 2008; Atlanta, GA.
26. Ned R, Yesupriya A, Imperatore G, Smelser D, Moonesinghe R. Polymorphisms in immune response and inflammation genes are associated with chronic kidney disease in U.S. population: data from NHANES III. Poster presented at: Centers for Disease Control and Prevention Public Health Genomics Meeting; January 23, 2008; Atlanta, GA.
27. Khoury MJ, Yang Q, Gwinn M, Little J, Flanders WD. An epidemiologic of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med. 2004;6(1):38-47. (Pubitemid 38175976)
28. Baker C. Your genes, your choices: exploring the issues raised by genetic research. http://www.ornl.gov/sci/techresources/Human-Genome/publicat/ genechoice/yourgenes.pdf. Last accessed January 12, 2009.
29. Tate SK, Goldstein DB. Will tomorrow's medicines work for everyone? Nat Genet. 2004;36:S34-S42.
30. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170-1175. (Pubitemid 36337330)
31. Schwartz RS. Racial profiling in medical research. N Engl J Med. 2001;344:1392-1393
32. Kolata G. Genes explain race disparity in response to a heart drug. New York Times.April 29, 2008. http://www.nytimes.com/2008/04/29/health/research/ 29heart.html. Last accessed August 13, 2009.
33. Royal CDM, Dunston GM. Changing the paradigm from 'race' to human genome variation. Nat Genet. 2004;36(11)(Suppl): S5-S7.
34. Harty L, Johnson K, Power A. Race and ethnicity in the era of emerging pharmacogenomics. J Clinical Pharmacol. 2006;99: 405-407.
35. Yancy CW. Race-based therapeutics. Curr Hypertens Rep. 2008;10:276-285.
36. Lee SS, Mountain J, Koenig BA. The meaning of "race" in the new genomics: implications for health disparities research. Yale J Health Policy Law Ethics. 2001;17:33-75.
37. Patrinos A. 'Race' and the human genome. Nature Genetics. 2004;36(11)(Suppl):S1-S2.
38. Feero WG, Guttmacher AE, Collins FS. The genome gets personal - almost. JAMA. 2008;299(11):1351-1352.
39. Aaron HJ, Schwartz WB. Can We Say No? Washington, DC: Brookings Institution; 2005.
40. Hall MJ, Olopade OI. Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol. 2006;24(14):2197-2203.
41. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle - will we get our wish? N Engl J Med. 2008;358(2):105-107.
42. Khoury MJ, Gwynn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9(10):6654-6674.
43. Katsanis SH, Javitt G, Hudson K. A case study of personalized medicine. Science. 2008 Apr 4;320(5872):53-54.
44. Bio-Medicine. Genetic testing market to exceed $6.6 billion by 2015, according to new report by Global Industry Analysts, Inc. http://www.bio-medicine.org/biology-technology-1/Genetic-Testing-Market-to- Exceed-246-6-Billion-by-2015-According-to-New-Reportby- Global-Industry- Analysts-Inc-8728-2/. Published October 30, 2008. Last accessed January 12, 2009.
45. Dacus H, Greendale K, Burke B, Negussie E, Boddie-Wells C. Preparing for a direct-toconsumer marketing campaign for BRCA1 and BRCA2 testing: a three state public health collaboration. Poster presented at: Centers for Disease Control and Prevention Public Health Genomics Meeting; January 23, 2008; Atlanta, GA.
46. Piper MA, Lindenmayer JM, Lengerich EJ, et al. The role of state public health agencies in genetics and disease prevention: results of a national survey. Public Health Rep. 2001;116: 22-31.
47. Khoury MJ, Jones K, Grosse SD. Quantifying the health benefits of genetic tests: the importance of a population perspective. Genet Med. 2006;8(3):191-195. (Pubitemid 43756071)
48. Johnson TD. Genomics heralded as new tool for improving public health. The Nation's Health. May 1, 2008. http://www.apha.org/publications/tnh/archives/ 2008/May+2008/Nation/GenomicsNAT.htm. Last accessed August13, 2009.
49. Berg AO, Kaye C, Bradley L, et al. Evidence-based evaluation of genetic testing: the EGAPP Initiative. Poster presented at: Centers for Disease Control and Prevention Public Health Genomics Meeting; January 23, 2008; Atlanta, GA.
50. Burke W, Khoury MJ, Stewart A, Zimmern RL. The path from genome-based research to population health: development of an international public health genomics network. Genet Med. 2006;8(7):451-458 (Pubitemid 44289008)